BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12183550)

  • 1. Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice.
    Rosinha GM; Freitas DA; Miyoshi A; Azevedo V; Campos E; Cravero SL; Rossetti O; Splitter G; Oliveira SC
    Infect Immun; 2002 Sep; 70(9):5036-44. PubMed ID: 12183550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella abortus tandem repeated ATP-binding proteins, BapA and BapB, homologs of haemophilus influenzae LktB, are not necessary for intracellular survival.
    Ko J; Splitter GA
    Microb Pathog; 2000 Oct; 29(4):245-53. PubMed ID: 10993743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and characterization of cgt, the Brucella abortus cyclic beta-1,2-glucan transporter gene, and its role in virulence.
    Roset MS; Ciocchini AE; Ugalde RA; Iñón de Iannino N
    Infect Immun; 2004 Apr; 72(4):2263-71. PubMed ID: 15039351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of the Rhizobium meliloti succinoglycan biosynthesis gene cluster: identification of the exsA gene encoding an ABC transporter protein, and the exsB gene which probably codes for a regulator of succinoglycan biosynthesis.
    Becker A; Küster H; Niehaus K; Pühler A
    Mol Gen Genet; 1995 Dec; 249(5):487-97. PubMed ID: 8544814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
    Wang Z; Niu J; Wang S; Lv Y; Wu Q
    Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants.
    Iñón de Iannino N; Briones G; Tolmasky M; Ugalde RA
    J Bacteriol; 1998 Sep; 180(17):4392-400. PubMed ID: 9721274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Brucella abortus RecA mutant and its survival in mice.
    Tatum FM; Morfitt DC; Halling SM
    Microb Pathog; 1993 Mar; 14(3):177-85. PubMed ID: 8321120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival.
    LeVier K; Phillips RW; Grippe VK; Roop RM; Walker GC
    Science; 2000 Mar; 287(5462):2492-3. PubMed ID: 10741969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers.
    Campos E; Cravero SL; Delgui L; Mora I; Kahn N; Arese AI; Rossetti OL
    Vet Microbiol; 2002 Jun; 87(1):1-13. PubMed ID: 12079742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.
    Zhu J; Larson CB; Ramaker MA; Quandt K; Wendte JM; Ku KP; Chen F; Jourdian GW; Vemulapalli R; Schurig GG; He Y
    Front Cell Infect Microbiol; 2011; 1():10. PubMed ID: 22919576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
    Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW; Brees D
    Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence.
    McQuiston JR; Vemulapalli R; Inzana TJ; Schurig GG; Sriranganathan N; Fritzinger D; Hadfield TL; Warren RA; Lindler LE; Snellings N; Hoover D; Halling SM; Boyle SM
    Infect Immun; 1999 Aug; 67(8):3830-5. PubMed ID: 10417145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, characterization and construction of htrA and htrA-like mutants of Brucella abortus and their survival in BALB/c mice.
    Tatum FM; Cheville NF; Morfitt D
    Microb Pathog; 1994 Jul; 17(1):23-36. PubMed ID: 7861951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation.
    Rosinha GMS; Myioshi A; Azevedo V; Splitter GA; Oliveira SC
    J Med Microbiol; 2002 Aug; 51(8):661-671. PubMed ID: 12171297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.
    Vemulapalli R; He Y; Buccolo LS; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jul; 68(7):3927-32. PubMed ID: 10858205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
    Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
    Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the BCSP31 gene of Brucella abortus by replacement.
    Halling SM; Detilleux PG; Tatum FM; Judge BA; Mayfield JE
    Infect Immun; 1991 Nov; 59(11):3863-8. PubMed ID: 1937745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brucella abortus Lon functions as a generalized stress response protease and is required for wild-type virulence in BALB/c mice.
    Robertson GT; Kovach ME; Allen CA; Ficht TA; Roop RM
    Mol Microbiol; 2000 Feb; 35(3):577-88. PubMed ID: 10672180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.